Extending the dosing range for simvastatin: The efficacy and safety of Simvastatin 80 mg/d

被引：0

作者：

Ose, L ^{[1
]}

Corsetti, LA ^{[1
]}

Tate, AC ^{[1
]}

Shahane, A ^{[1
]}

Mitchel, YB ^{[1
]}

机构：

[1] MERCK RES LABS,RAHWAY,NJ

来源：

ATHEROSCLEROSIS | 1997年 / 134卷 / 1-2期

关键词：

D O I：

10.1016/S0021-9150(97)88706-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：131 / 131

页数：1

共 50 条

[21] SAFETY, TOLERABILITY, AND EFFICACY OF SIMVASTATIN AND FENOFIBRATE - A MULTICENTER STUDY [J].

ZIEGLER, O ;

DROUIN, P .

CARDIOLOGY, 1990, 77 :50-57

[22] Efficacy and safety of Simvastatin for high-risk hypercholesterolemia [J].

Mölgaard, J ;

Wärjerstam-Elf, S ;

Olsson, AG .

AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (07) :1043-1048

[23] Efficacy and safety of oral simvastatin in the treatment of patients with vitiligo [J].

Zhang, Shiyu ;

Zdravkovic, Tanja Prunk ;

Wang, Tao ;

Liu, Yuehua ;

Jin, Hongzhong .

JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) :393-396

[24] Translated Paper: Comparison of efficacy and safety of atorvastatin (10 mg) and simvastatin (10 mg) at six weeks. [J].

Insull, W ;

Kafonek, S ;

Goldner, D .

PERFUSION, 2001, 14 (06) :244-250

[25] Safety and efficacy of enalapril and simvastatin in dialysis patients. [J].

Collins, JF ;

Robson, R ;

MacMahon, S .

KIDNEY INTERNATIONAL, 1996, 50 (04) :1410-1410

[26] COMPARISON OF THE EFFICACY, SAFETY AND TOLERABILITY OF SIMVASTATIN AND PRAVASTATIN - REPLY [J].

SWEANY, AE ;

SHAPIRO, DR ;

TATE, AC .

AMERICAN JOURNAL OF CARDIOLOGY, 1994, 73 (09) :723-724

[27] Simvastatin in management of patients with primary hypercholesterolemia: Tolerability and efficacy of daily doses 10-80 mg [J].

Susekov, AV ;

Solovyeva, EY ;

Rozhkova, TA ;

Kotova, LA ;

Akhmedova, ZA ;

Kukharchuk, VV .

KARDIOLOGIYA, 2002, 42 (01) :33-36

[28] LONG-TERM SAFETY AND EFFICACY PROFILE OF SIMVASTATIN [J].

BOCCUZZI, SJ ;

BOCANEGRA, TS ;

WALKER, JF ;

SHAPIRO, DR ;

KEEGAN, ME .

AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (11) :1127-1131

[29] COMPARISON OF THE EFFICACY, SAFETY AND TOLERABILITY OF SIMVASTATIN AND PRAVASTATIN FOR HYPERCHOLESTEROLEMIA [J].

DAUBRESSE, JC ;

DEBACKER, G ;

DUCOBU, J ;

HARVENGT, C ;

DEGENNES, JL ;

DOUSTEBLAZY, P ;

FARNIER, M ;

ANDERS, G ;

DAMMANN, HG ;

NEUMANN, E ;

SCHWARZE, B ;

SEIFART, C ;

KASTELEIN, J ;

STALENHOEF, A ;

KEIDAR, S ;

CAPURSO, A ;

DECESARIS, R ;

DESCOVICH, G ;

FELLIN, R ;

FERUGLIO, F ;

MALINI, P ;

TRIMARCO, B ;

SCOTT, R ;

MARAIS, A ;

KELLER, U ;

MOCCETTI, T ;

BLOOMFIELD, P ;

CRAMB, R ;

HUGHES, E ;

SEED, M ;

WRAY, R ;

STEIN, E ;

FRUCHART, J ;

SWEANY, A ;

SHAPIRO, D ;

TATE, A .

AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (16) :1408-1414

[30] THE EFFICACY AND SAFETY OF PRAVASTATIN AND SIMVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA [J].

VOLPE, R ;

ARCA, M ;

GINNETTI, MG ;

ANTONINI, R ;

RICCI, G ;

URBINATI, G .

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1992, 51 (03) :422-430

← 1 2 3 4 5 →